Utility and validity of the self-administered SF-36: Findings from an older population

Annals of the Academy of Medicine Singapore

Volumn 35, Issue 7, 2006, Pages 461-467

  Chia, Ee Munn ^a   Chia, Ee May ^a   Rochtchina, Elena ^a   Jie, Jin Wang ^a   Mitchell, Paul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Ageing; Cognitive impairment; Quality of life; SF 36; Validity; Visual impairment

Indexed keywords

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; VALIDITY; VISUAL IMPAIRMENT;

EID: 33749017954     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. McDowell I, Newell C. Measuring Health. A Guide to Rating Scales and Questionnaires. 2nd ed. New York: Oxford University Press, 1996.
2. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:619-26.
3. Globe DR, Levin S, Chang TS, Mackenzie PJ, Azen S. Validity of the SF-12 quality of life instrument in patients with retinal diseases. Ophthalmology 2002;109:1793-8.
4. McHorney CA. Measuring and monitoring general health status in elderly persons: practical and methodological issues in using the SF-36 Health Survey. Gerontologist 1996;36:571-83.
5. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
6. Cumming RG, Salkeld G, Thomas M, Szonyi G. Prospective study of the impact of fear of falling on activities of daily living, SF-36 scores, and nursing home admission. J Gerontol A Biol Sci Med Sci 2000;55:M299-M305.
7. Kroenke K, West SL, Swindle R, Gilsenan A, Eckert GJ, Dolor R, et al. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA 2001;286:2947-55.
8. Cohen HJ, Feussner JR, Weinberger M, Carnes M, Hamdy RC, Hsieh F, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002;346:905-12.
9. Hobart JC, Williams LS, Moran K, Thompson AJ. Quality of life measurement after stroke: uses and abuses of the SF-36. Stroke 2002;33:1348-56.
10. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Impact of diabetes screening on quality of life. Diabetes Care 2002;25:1022-6.
11. Hays RD, Hahn H, Marshall G. Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities. Arch Phys Med Rehabil 2002;83:S4-S9.
12. Baker F, Haffer SC, Denniston M. Health-related quality of life of cancer and noncancer patients in Medicare managed care. Cancer 2003;97:674-81.
13. Chia EM, Mitchell P, Rochtchina E, Foran S, Wang JJ. Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study. Br J Ophthalmol 2003;87:392-5.
14. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160-4.
15. Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ 1993;306:1437-40.
16. Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993;306:1440-4.
17. McCallum J. The SF-36 in an Australian sample: validating a new, generic health status measure. Aust J Public Health 1995;19:160-6.
18. Hayes V, Morris J, Wolfe C, Morgan M. The SF-36 health survey questionnaire: is it suitable for use with older adults? Age Ageing 1995;24:120-5.
19. Singleton N, Turner A. Measuring patients' views of their health. SF 36 is suitable for elderly patients. BMJ 1993;307:126-7.
20. Lyons RA, Perry HM, Littlepage BN. Evidence for the validity of the Short-form 36 Questionnaire (SF-36) in an elderly population. Age Ageing 1994;23:182-4.
21. Walters SJ, Munro JF, Brazier JE. Using the SF-36 with older adults: a cross-sectional community-based survey. Age Ageing 2001;30:337-43.
22. Parker SG, Peet SM, Jagger C, Farhan M, Castleden CM. Measuring health status in older patients. The SF-36 in practice. Age Ageing 1998;27:13-8.
23. Mallinson S. The Short-Form 36 and older people: some problems encountered when using postal administration. J Epidemiol Community Health 1998;52:324-8.
24. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol 1990;108:286-90.
25. Klein R, Klein BE, Linton KL, De Mets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology 1991;98:1310-5.
26. Salive ME, Guralnik J, Christen W, Glynn RJ, Colsher P, Ostfeld AM. Functional blindness and visual impairment in older adults from three communities. Ophthalmology 1992;99:1840-7.
27. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:357-64.
28. Di Carlo A, Baldereschi M, Amaducci L, Maggi S, Grigoletto F, Scarlato G, et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc 2000;48:775-82.
29. Unverzagt FW, Gao S, Baiyewu O, Ogunniyi AO, Gureje O, Perkins A, et al. Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001;57:1655-62.
30. Foran S, Rose K, Wang JJ, Mitchell P. Correctable visual impairment in an older population: the blue mountains eye study. Am J Ophthalmol 2002;134:712-9.
31. Wang JJ, Mitchell P, Smith W, Leeder SR. Factors associated with use of community support services in an older Australian population. Aust NZ J Public Health 1999;23:35-41.
32. Sanson-Fisher RW, Perkins JJ. Adaptation and validation of the SF-36 Health Survey for use in Australia. J Clin Epidemiol 1998;51:961-7.
33. Ware JE, Snow KK, Kosinski M, Gande B. SF-36 health survey. Manual and interpretation guide. Boston: Health Institute, New England Medical Center, 1993.
34. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales. Boston, Massachusetts: The Health Institute, New England Medical Center, 1994.
35. ABS. National Health Survey. SF-36 Population Norms. Australia. (4399.0). Canberra: ABS, 1997.
36. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
37. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
38. Nunnally JC. Psychometric Theory. 2nd ed. New York: Mc-Graw-Hill, 1978.
39. Hill S, Harries U, Popay J. Is the short form 36 (SF-36) suitable for routine health outcomes assessment in health care for older people? Evidence from preliminary work in community based health services in England. J Epidemiol Community Health 1996;50:94-8.
40. Watson EK, Firman DW, Baade PD, Ring I. Telephone administration of the SF-36 health survey: validation studies and population norms for adults in Queensland. Aust NZ J Public Health 1996;20:359-63.
41. Johansen A. SF 36 may reinforce ageism. BMJ 1993;307:127.